What is the clinical evidence from this study?

Study design: Review. Population: Atrial fibrillation.

What question did this study set out to answer?

This update aims to refine management strategies for atrial fibrillation based on new evidence and guidelines.

August 24, 2012European Heart JournalOpen Access

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

View Full Paper

Ask AI

Bookmark

This update aims to refine management strategies for atrial fibrillation based on new evidence and guidelines.
Focused update incorporating recent randomized controlled trials and clinical evidence
Recommendations on anticoagulation, rate control, rhythm control, and novel therapies
Analysis of stroke risk stratification and intervention techniques
Evidence suggests improved effectiveness of novel oral anticoagulants over traditional ones.
Rate control strategies demonstrate significant reductions in stroke risk compared to usual care.
Findings support the use of left atrial ablation and pulmonary vein isolation for symptomatic management.

Structured PICO

Population

Patients with atrial fibrillation

Intervention

Management of atrial fibrillation including anticoagulation, novel oral anticoagulants, left atrial appendage occlusion, rate control, cardioversion, rhythm control, and ablation

Provides the 2012 focused update to the European Society of Cardiology guidelines for the management of atrial fibrillation.

Implication

AF stroke risk models show limited real-world performance; leaves open need for updated, validated tools before guiding therapy.

Abstract

Atrial fibrillation; European Society of Cardiology; Guidelines; Anticoagulation; Novel oral anticoagulants; Left atrial appendage occlusion; Rate control; Cardioversion; Rhythm control; Antiarrhythmic drugs; Upstream therapy; Pulmonary vein isolation; Left atrial ablation; Focused update; RANDOMIZED CONTROLLED-TRIAL; HEART RHYTHM ASSOCIATION; NET CLINICAL BENEFIT; RE-LY TRIAL; STROKE RISK STRATIFICATION; ACUTE CORONARY SYNDROME; RADIOFREQUENCY CATHETER ABLATION; ANTIARRHYTHMIC-DRUG THERAPY; ORAL ANTICOAGULANT DRUGS; NORMALIZED RATIO CONTROL

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Members et al. (2012) conducted a review in Atrial fibrillation. The 2012 focused update of the ESC Guidelines provides updated recommendations for the management of atrial fibrillation, including anticoagulation, rate control, and rhythm control strategies.

synapsesocial.com/papers/6a6a660426cff2e2f6f40789 https://doi.org/10.1093/eurheartj/ehs253